HR Execs on the Move

TrueAbility

www.trueability.com

 
TrueAbility was founded to give technical professionals a platform to prove their skills, and to make it easier for companies to find, assess, and hire technical talent. The founders collectively hired over 1100 system administrators, network administrators, developers, and other technical employees during their careers at a leading global technology company. Frustration with the technical recruiting process led to the creation of TrueAbility.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Quri

Quri is a retail intelligence and analytics company. Quri gives consumer brands and retailers the visibility to see what their shoppers are seeing and the analytics to immediately correct the problems they find. Quri uses crowdsourcing, via its own nationwide force of consumers, to measure store-by-store execution gaps so you can immediately alert your field team to take corrective action. As a result, Quri helps drive much better shopping experiences for shoppers and higher in-store sales and ROI for you.

Novel Staffing

Novel Staffing is a Dallas, TX-based company in the Software & Internet sector.

ItsaCheckmate

The page is about connecting with fans who like our services, and brand

VAYU ENGINEERING SOLUTIONS

VAYU ENGINEERING SOLUTIONS is a Waterbury, CT-based company in the Software & Internet sector.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.